Skip to main content

Table 2 Clinical characteristics of tuberculosis patients by HIV Status (n = 10,156)

From: Tuberculosis treatment outcomes: a fifteen-year retrospective study in Jos-North and Mangu, Plateau State, North - Central Nigeria

Variable

HIV Negative (n = 3733) Freq. (%)

HIV Positive (n = 2968) Freq. (%)

Unknown HIV Status (n = 3455) Freq. (%)

Total Freq. (%)

TB Diagnosis

 Pulmonary TB

3311 (88.7)

2818 (94.9)

3258 (94.3)

9387 (92.4)

 Extra-PTB

422 (11.3)

150 (5.1)

197 (5.7)

769 (7.6)

 TB Spine

227 (6.1)

29 (1.0)

92 (2.7)

348 (3.4)

 TB Adenitis

39 (1.0)

22 (0.7)

19 (0.5)

80 (0.8)

 TB Abdomen

135 (3.6)

91 (3.1)

61 (1.8)

287 (2.8)

 Othersa

21 (0.6)

8 (0.3)

25 (0.7)

54 (0.5)

TB Category

 New

3405 (91.2)

2778 (93.6)

3290 (95.2)

9473 (93.3)

 RAD/TALF

104 (2.8)

59 (2.0)

55 (1.6)

218 (2.1)

 Relapse

161 (4.3)

72 (2.4)

49 (1.4)

282 (2.8)

 Trt. Failure

11 (0.3)

7 (0.2)

1 (0.0)

19 (0.2)

 Transfer-In

52 (1.4)

52 (1.8)

60 (1.7)

164 (1.6)

Needing Retreatment

 No

3290 (88.1)

2704 (91.1)

2979 (86.2)

8973 (88.4)

 Yes

282 (7.6)

136 (4.6)

104 (3.0)

522 (5.1)

 Indeterminateb

161 (4.3)

128 (4.3)

372 (10.8)

661 (6.5)

Sputum AFB on Diagnosis

 Sputum Negative

2355 (63.1)

2398 (80.8)

2480 (71.8)

7233 (71.2)

 Sputum AFB Positive

1378 (36.9)

570 (19.2)

975 (28.2)

2923 (28.8)

Sputum AFB After Intensive Phase

 Sputum Negative

3510 (94.0)

2806 (94.5)

3044 (88.1)

9360 (92.2)

 Sputum AFB Positive

39 (1.0)

18 (0.6)

12 (0.3)

69 (0.7)

 Indeterminateb

184 (4.9)

144 (4.9)

398 (11.5)

726 (7.1)

Defaulting Period (n = 1874)

 During Intensive Phase

97 (2.6)

65 (2.2)

271 (7.8)

433 (4.3)

 End of Intensive Phase

190 (5.1)

191 (6.4)

559 (16.2)

940 (9.3)

 Continuation Phase

96 (2.6)

62 (2.1)

343 (9.9)

501 (4.9)

Binary Outcome

 Unsuccessful

919 (24.6)

781 (26.3)

1599 (46.3)

3299 (32.5)

 Successful

2814 (75.4)

2187 (73.7)

1855 (53.7)

6856 (67.5)

  1. a=Disseminated TB, Miliary TB, Ovarian TB, Pleural TB, Skin TB, Heart TB
  2. bIndeterminate due to lost to follow-up or death during intensive phase of treatment RAD Return after Default, TALF Treatment after lost to follow up, Trt Treatment